News Releases

BOTHELL, Wash., Sept. 7, 2017 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media ("BioLife"), announces that Mike Rice, President and CEO, will be presenting at two investment conferences in September: 

• Rodman & Renshaw 19^th Annual Global Investment Conference on Tuesday, September 12th, at 3:25 p.m. Eastern time (12:25 p.m. Pacific time). The conference is being held at the New York Palace Hotel in New York City
• Janney Montgomery Scott Bioproduction & Biostorage Forum on Tuesday, September 19^th, at the Union League Club in New York City

About BioLife Solutions

BioLife Solutions develops, manufactures and markets biopreservation media products and smart shipping containers connected to a cloud hosted cold chain management app to improve the quality of delivery logistics for cells, tissues, and organs. The Company's proprietary HypoThermosol^® and CryoStor^® platform of solutions are highly valued in the regenerative medicine, biobanking, and drug discovery markets. BioLife's biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death. BioLife's enabling technology provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs.  For more information please visit www.biolifesolutions.com, and follow BioLife on Twitter.

Contact:
Roderick de Greef
Chief Financial Officer
(425) 686-6002
rdegreef@biolifesolutions.com

SOURCE BioLife Solutions, Inc.